Development of an Analytical Method for Determination of Related Substances and Degradation Products of Cabotegravir Using Analytical Quality by Design Principles

[Image: see text] Cabotegravir is one of the newly approved human immunodeficiency virus (HIV) integrase enzyme inhibitors used for the prevention and treatment of HIV infection. It is the first approved long-acting injectable antiretroviral therapy for HIV and is also very effective in combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovač, Lidija, Časar, Zdenko, Trdan Lušin, Tina, Roškar, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928553/
https://www.ncbi.nlm.nih.gov/pubmed/35309479
http://dx.doi.org/10.1021/acsomega.1c07260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928553/
https://www.ncbi.nlm.nih.gov/pubmed/35309479
http://dx.doi.org/10.1021/acsomega.1c07260

Ejemplares similares